Don’t Count on Lower Premiums Despite Pandemic-Driven Boon for Insurers
(By Bernard J. Wolfson for Kaiser Health News) When COVID-19 smacked the United States in March and April, health plans
Read More
Emerging Health Issues
So far this year, Medicare has paid $2.8 billion for COVID-19 hospitalizations
According to updated data from CMS, so far this year, Medicare payments for fee-for-service COVID-19 hospitalizations have totaled $2.8 billion.
Read MoreOhio’s board of pharmacy bans hydroxychloroquine for use in COVID-19 patients
(By Maia Anderson for Becker’s Hospital Review) Ohio’s board of pharmacy has banned hydroxychloroquine as a COVID-19 treatment. As of July 30, pharmacists
Read MoreFDA puts hand sanitizers on import alert, adds more to do-not-use list
(By Maia Anderson for Becker’s Hospital Review) The FDA has placed certain brands of hand sanitizer on an import alert as more
Read MoreCovid-19 infections leave an impact on the heart, raising concerns about lasting damage
(By Elizabeth Cooney for STAT) Two new studies from Germany paint a sobering picture of the toll that Covid-19 takes
Read MoreDemand Surges For See-through Face Masks As Pandemic Swells
(By Yuki Noguchi for NPR) Blake Blackmon and his fiance, Jessica Cournoyer, recently welcomed their second child, a cherubic-cheeked good
Read MoreLast Thing Patients Need During Pandemic: Being Last to Know a Doctor Left Network
(By Michelle Andrews for Kaiser Health News) NEW YORK — As the coronavirus spread silently through New York City early
Read MorePandemic could spur Medicare trust fund depletion by 2022, former VA chief says
(By Alia Paavola for Becker’s Hospital Review) The coronavirus pandemic could spur the depletion of the Medicare Part A trust fund
Read MoreTrump Administration Announces New Resources to Protect Nursing Home Residents Against COVID-19
(Source – www.cms.gov/newsroom) As part of the unprecedented efforts taken by the Trump Administration, President Trump today announced several new
Read MoreNIH to start ‘flurry’ of large studies of potential Covid-19 treatments
(By Matthew Herper for STAT) The National Institutes of Health is preparing to launch a “flurry” of large clinical trials
Read More